Iodoxamic acid

DB13539ExperimentalSmall molecule

Radiopaque medium used in the diagnosis of gall bladder & bile duct diseases, usually as meglumine salt.

Chemical structure of Iodoxamic acid
Formula / weight
C26H26I6N2O10 · 1287.925 g/mol (avg)
Code names
B-10610 · BC-17 · SQ-21982

Resolves to

Compound
UNIINS1Y283HW4CAS31127-82-9ChEMBLCHEMBL1615487ChEBI31707
Clinical / RWD
RxNorm51471ATCV08AC01
Structure
InChIKeyWWVAPFRKZMUPHZ-UHFFFAOYSA-NSMILESOC(=O)C1=C(I)C(NC(=O)CCOCCOCCOCCOCCC(=O)NC2=C(I)C(C(O)=O)=C(I)C=C2I)=C(I)C=C1I

What you can answer from here — as of September 13, 2026

1ATC codeIncluding every combination product, plus 9 drug categories
Sign in

Which companies are running trials of Iodoxamic acid, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In